Alcohol and Metabolic-associated Fatty Liver Disease

被引:10
|
作者
Sun, Fu-Rong [1 ]
Wang, Bing-Yuan [1 ]
机构
[1] China Med Univ, Dept Elderly Gastroenterol, First Hosp, Shenyang, Liaoning, Peoples R China
关键词
Alcohol; Metabolic-associated fatty liver disease; Obesity; Insulin resistance; Hypertension; CARDIOVASCULAR RISK-FACTORS; HIGH-DENSITY-LIPOPROTEINS; KOREA NATIONAL-HEALTH; BODY-MASS INDEX; BLOOD-PRESSURE; INSULIN SENSITIVITY; RED WINE; BEVERAGE CONSUMPTION; CHINESE POPULATION; ACID METABOLISM;
D O I
10.14218/JCTH.2021.00173
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
The diagnosis of metabolic-associated fatty liver disease is based on the detection of liver steatosis together with the presence of metabolic dysfunction. According to this new defi-nition, the diagnosis of metabolic-associated fatty liver disease is independent of the amount of alcohol consumed. Actually, alcohol and its metabolites have various effects on metabolic-associated abnormalities during the process of alcohol me-tabolism. Studies have shown improved metabolic function in light to moderate alcohol drinkers. There are several studies focusing on the role of light to moderate alcohol intake on metabolic dysfunction. However, the results from studies are diverse, and the conclusions are often controversial. This re-view systematically discusses the effects of alcohol consump-tion, focusing on light to moderate alcohol consumption, on obesity, lipid and glucose metabolism, and blood pressure. Citation of this article: Sun FR, Wang BY. Alcohol and metabolic-associated fatty liver disease. J Clin Transl Hepa-tol 2021. doi: 10.14218/JCTH.2021.00173.
引用
收藏
页码:719 / 730
页数:12
相关论文
共 50 条
  • [31] Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease
    Martin-Grau, Maria
    Monleon, Daniel
    WORLD JOURNAL OF CLINICAL CASES, 2023, 11 (06) : 1236 - 1244
  • [32] Sex dimorphism and metabolic profiles in management of metabolic-associated fatty liver disease
    Maria Martin-Grau
    Daniel Monleon
    World Journal of Clinical Cases, 2023, (06) : 1236 - 1244
  • [33] From nonalcoholic fatty liver disease to metabolic-associated fatty liver disease: Big wave or ripple?
    Kang, Seong Hee
    Cho, Yuri
    Jeong, Soung Won
    Kim, Seung Up
    Lee, Jin-Woo
    CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (02) : 257 - 269
  • [34] Muscle strength and non-alcoholic fatty liver disease/metabolic-associated fatty liver disease
    Hao, Xuan-Yu
    Zhang, Kai
    Huang, Xing-Yong
    Yang, Fei
    Sun, Si-Yu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2024, 30 (07) : 636 - 643
  • [35] Ecological shifts of salivary microbiota associated with metabolic-associated fatty liver disease
    Wang, Min
    Yan, Li-Ya
    Qiao, Cai-Yun
    Zheng, Chu-Chu
    Niu, Chen-Guang
    Huang, Zheng-Wei
    Pan, Yi-Huai
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13
  • [36] A Form of Metabolic-Associated Fatty Liver Disease Associated with a Novel LIPA Variant
    Anushiravani, Amir
    Khamirani, Hossein Jafari
    Mohamadkhani, Ashraf
    Mani, Arya
    Dianatpour, Mehdi
    Malekzadeh, Reza
    ARCHIVES OF IRANIAN MEDICINE, 2023, 26 (02) : 86 - 91
  • [37] Mechanisms Linking Metabolic-Associated Fatty Liver Disease (MAFLD) to Cardiovascular Disease
    Olufunto O. Badmus
    Terry D. Hinds
    David E. Stec
    Current Hypertension Reports, 2023, 25 : 151 - 162
  • [38] Metabolic-associated fatty liver disease is associated with severity of COVID-19
    Zhou, Yu-Jie
    Zheng, Kenneth, I
    Wang, Xiao-Bo
    Sun, Qing-Feng
    Pan, Ke-Hua
    Wang, Ting-Yao
    Ma, Hong-Lei
    Chen, Yong-Ping
    George, Jacob
    Zheng, Ming-Hua
    LIVER INTERNATIONAL, 2020, 40 (09) : 2160 - 2163
  • [39] Metabolic-associated fatty liver disease and the role of hormones in its aetiopathogenesis
    Suwala, Szymon
    Junik, Roman
    ENDOKRYNOLOGIA POLSKA, 2024, 75 (03) : 237 - 252
  • [40] Altered lipid metabolism and the development of metabolic-associated fatty liver disease
    Foster, Christy
    Gagnon, Charles A.
    Ashraf, Ambika P.
    CURRENT OPINION IN LIPIDOLOGY, 2024, 35 (04) : 200 - 207